News Release

Stem cells can use same method as plants and insects to protect against viruses

Peer-Reviewed Publication

The Francis Crick Institute

Researchers at the Francis Crick Institute have found a vital mechanism, previously thought to have disappeared as mammals evolved, that helps protect mammalian stem cells from RNA viruses such as SARS-CoV-2 and Zika virus. The scientists suggest this could one day be exploited in the development of new antiviral treatments.

On infecting a host, a virus enters cells in order to replicate. For most cells in mammals the first line of protection are proteins, called interferons. Stem cells, however, lack the ability to trigger an interferon response and there has been uncertainty about how they protect themselves.

In their study, published in Science today (8 July) the scientists analysed genetic material from mouse stem cells and found it contains instructions to build a protein, named antiviral Dicer (aviD), which cuts up viral RNA and so prevents RNA viruses from replicating. This form of protection is called RNA interference, which is the method also used by cells in plants and invertebrates.

Caetano Reis e Sousa, author and group leader of the Immunobiology Laboratory at the Crick says, "It's fascinating to learn how stem cells protect themselves against RNA viruses. The fact this protection is also what plants and invertebrates use suggests it might be something that goes far back in mammalian history, right up to when the evolutionary tree spilt. For some reason, while all mammalian cells possess the innate ability to trigger this process, it seems to only be relied upon by stem cells.

"By learning more about this process, and uncovering the secrets of our immune system we are hoping to open up new possibilities for drug development as we strive to harness our body's natural ability to fight infection."

In laboratory experiments which exposed engineered human cells to SARS-CoV-2, the virus infected three times fewer stem cells when aviD was present in the cells compared to when the researchers removed this protein.

The scientists also grew mini brain organoids from mouse embryonic stem cells and found that, when infected with Zika virus, the organoids with aviD grew more quickly and less viral material was produced than in organoids without this protein. Similarly, when organoids were infected with SARS-CoV-2, there were fewer infected stem cells in the organoids with aviD.

Enzo Poirier, author and postdoc in the Immunobiology Laboratory at the Crick says, "Why stem cells use this different mechanism of defence remains a mystery. It might be that the interferon process would cause too much harm to stem cells, so mammals, including humans, have evolved to shield these precious cells from this damage. There is still a lot of uncertainty about how these cells are protected from viruses, which we're excited to explore further."

The researchers will continue this work, creating a mouse model which allows them to further study the effects and importance of aviD in mammalian stem cells.


For further information, contact: or +44 (0)20 3796 5252

Notes to Editors

Reference: Poirier, E.Z. et al. (2021). An isoform of Dicer protects mammalian stem cells against multiple RNA viruses. Science. 10.1126/science.abg2264

The Francis Crick Institute is a biomedical discovery institute dedicated to understanding the fundamental biology underlying health and disease. Its work is helping to understand why disease develops and to translate discoveries into new ways to prevent, diagnose and treat illnesses such as cancer, heart disease, stroke, infections, and neurodegenerative diseases.

An independent organisation, its founding partners are the Medical Research Council (MRC), Cancer Research UK, Wellcome, UCL (University College London), Imperial College London and King's College London.

The Crick was formed in 2015, and in 2016 it moved into a brand new state-of-the-art building in central London which brings together 1500 scientists and support staff working collaboratively across disciplines, making it the biggest biomedical research facility under a single roof in Europe.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.